Exhibit 107
Calculation of Filing Fee Tables
Form S-8 |
(Form Type) |
PTC Therapeutics, Inc. |
(Exact Name of Registrant as Specified in its Charter) |
Table 1—Newly Registered Securities
| | | | | | | |
Security Type | Security Class Title | Fee Calculation Rule | Amount Registered (1) | Proposed Maximum Offering Price Per Unit | Maximum Aggregate Offering Price | Fee Rate | Amount of Registration Fee |
Equity | Common Stock, $0.001 par value per share | Other | 8,475,000 shares (2) | $26.07 (3) | $220,943,250 (3) | $92.70 per $1,000,000 | $20,482 |
Total Offering Amounts | | $220,943,250 | | $20,482 | |||
Total Fee Offsets | | | | - | |||
Net Fee Due | | | | $20,482 | |||
(1) | In accordance with Rule 416 under the Securities Act of 1933, as amended, this registration statement shall be deemed to cover any additional securities that may from time to time be offered or issued to prevent dilution resulting from stock splits, stock dividends or similar transactions. |
(2) | Reflects 8,475,000 additional shares issuable under the Amended and Restated 2013 Long-Term Incentive Plan, as a result of an increase approved by the stockholders of the registrant at its 2022 Annual Meeting of Stockholders on June 8, 2022. |
(3) | Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(h) of the Securities Act of 1933, as amended. The price per share and aggregate offering price are calculated on the basis of $26.07, the average of the high and low sale price of the registrant’s Common Stock on the Nasdaq Global Select Market on June 16, 2022 in accordance with Rule 457(c) under the Securities Act of 1933, as amended. |
